Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 2”

250 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 250 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768
What this trial is testing

Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer Disease
Institute for Molecular Medicine 160
Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Not applicableStudy completedNCT00178568
What this trial is testing

Reducing Caregiver Stress and Sleep Disturbances in Patients With Progressive Dementia

Who this might be right for
Sleep Disorders
Kathy Kennedy 60
Testing effectiveness (Phase 2)Study completedNCT00099710
What this trial is testing

Curcumin in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
John Douglas French Foundation 33
Very early researchEnded earlyNCT03757910
What this trial is testing

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Who this might be right for
Alzheimer Disease
José A. Luchsinger 5
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00945672
What this trial is testing

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 36
Not applicableStudy completedNCT03702465
What this trial is testing

Assessment of the Impact of a Personalised Nutrition Intervention in Impaired Glucose Regulation

Who this might be right for
Pre Diabetes
Imperial College London 180
Not applicableStudy completedNCT01231971
What this trial is testing

Alzheimer's Disease Neuroimaging Initiative 2

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer's Disease (AD)Significant Memory Concern (SMC)+2 more
University of Southern California 1,182
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)UnknownNCT00753662
What this trial is testing

Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tel-Aviv Sourasky Medical Center 45
Not applicableLooking for participantsNCT05733520
What this trial is testing

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

Who this might be right for
Caregiver BurdenAlzheimer Disease
Indiana University 184
Large-scale testing (Phase 3)Study completedNCT00253188
What this trial is testing

The Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 653
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Large-scale testing (Phase 3)Study completedNCT03823404
What this trial is testing

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cortexyme Inc. 643
Not applicableStudy completedNCT05847153
What this trial is testing

MASC: Reducing Stress for Caregivers

Who this might be right for
Alzheimer Disease and Related DementiasDementia Alzheimers
Massachusetts General Hospital 13
Early research (Phase 1)Study completedNCT00494962
What this trial is testing

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT00117650
What this trial is testing

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Who this might be right for
Intermittent ClaudicationPeripheral Vascular DiseaseAtherosclerosis
Genzyme, a Sanofi Company 289
Post-approval studies (Phase 4)Study completedNCT00561392
What this trial is testing

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 208
Testing effectiveness (Phase 2)Study completedNCT01409915
What this trial is testing

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of Colorado, Denver 44
Next Page